NLRP3 and obesity due to melanocortin 4 receptor deficiency: Additively, PQQ possesses pharmacological effects on mitigating NLRP3 inflammasome-mediated pyroptosis to block the progression of inflammatory disease such as diabetes and obesity [22–24].